Sponsored Links / Ads

Skin Cancer

Recent Skin Cancer News
Novartis gets FDA approval for skin cancer drug combination

n">Novartis AG said on Friday it received the U.S. Food and Drug Administration's regular approval for a drug combination to treat an aggressive form of skin cancer.... [via Reuters]

FDA expands lung cancer approval for Bristol-Myers' drug

n">The U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co's immunotherapy drug Opdivo for patients with an additional form of advanced lung cancer.... [via Reuters]

Citrus Fruit Consumption May Be Associated With Increased Melanoma Risk | ASCO.org

ASCO Perspective Gary Schwartz, MD, ASCO ExpertThis study adds to the growing discussion around food and cancer risk.... [via ASCO]

Drug to treat advanced Melanoma approved for new early access scheme in UK

The treatment had been cleared to treat adults and children from 12 years of age with advanced melanoma, the deadliest form of skin cancer, after other drugs had failed.... [via Reuters]

Melanoma Drug Combo Improves Patient Survival Rate, Decreases Risk of Harsh Side Effect

STORY HIGHLIGHTS A UCLA researcher at the Jonsson Comprehensive Cancer Center has helped pioneer a new therapy that combines the drug Zelboraf with an experimental drug cobimetinib, allowing ... [via UCLA]

FDA Approves Game-Changing Melanoma Drug that Turns on Immune System to Fight Deadly Cancers

STORY HIGHLIGHTS The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.... [via UCLA]

Hospitals see rapid rise in skin cancer

Dermatologist Dr Walayat Hussain says the UK is experiencing "a tsunami of skin cancer" The cost of this treatment - mostly for surgery to cut the tumours out - now stands at more than 95m a year.... [via BBC]

Top end suncreams fail SPF test as cheaper lotions pass

For a better experience on your device, try our mobile site.... [via BBC]

Amgen vaccine triggers immune response in advanced melanoma -study

An experimental Amgen Inc cancer vaccine used to treat advanced melanoma, the deadliest form of skin cancer, proved effective in a late-stage study in shrinking tumors in a way that suggests the drug ... [via Reuters]

UV Light Accelerates Cancer Cells That Live Outside Blood Vessels

STORY HIGHLIGHTS Based on the pioneering work of Dr. Claire Lugassy and Dr.... [via UCLA]

Video on skin aging inspires teen sunscreen use

Teenagers felt more compelled to apply sunscreen if they saw in a video that it could protect their skin from premature aging than if they saw that it could protect against cancer, a new study shows.... [via Reuters]

Long-term Research Confirms Game-Changing Method for Detecting Spread of Deadly Skin Cancer

STORY HIGHLIGHTS Long-term research initiated at UCLAs Jonsson Comprehensive Cancer Center on techniques used for detecting the earliest spread of melanoma has confirmed that thesenew methods ... [via UCLA]

Indoor tanning common in Western countries: study

More than a third of adults in Western countries have been exposed to indoor tanning at some point, according to an analysis of past research.... [via Reuters]

Alcohol linked to skin cancer risk

Scientists believe drinking too much alcohol could set off a chain of reactions in the body that makes the skin more vulnerable to cancer.... [via BBC]

Men 'more vulnerable' to skin cancer

Adeyinka Ebo from Cancer Research UK says the figures may be partly down to men avoiding their GPs Far more men than women are dying from skin cancer, despite similar numbers being diagnosed with the ... [via BBC]

Featured Skin Cancer Articles

Melanoma Clinical Trial Uses Immunotherpy and Targeted Treatmens 
 An estimated 70,000 new cases of metastatic melanoma are diagnosed each year in the United States, and of those 8,000 will die of the disease. About 50 percent of these men and women (or 35,000 a year... [more]

Melanoma: Watch Your Back 
  Each year over a million people in the United States alone will be diagnosed with skin cancer. Of these, approximately 80,000 will be afflicted with melanoma. The incidence or the number of new c... [more]

Melanoma Drug Trial News: FDA approves new drug for advanced melanoma 
 BOSTON— March 25, 2011: Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or ... [more]

Skin Cancer Bookstore 
 Skin Cancer Book book section of CancerNews.com. Books related to skin cancer treatment, prevention, screening, survival and support.... [more]

Melanoma Research News: Gene Identified That Strong Affects Risk for Most Forms of Melanoma 
 Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have identified a link between inherited and acquired genetic factors that dramatically increase the chan... [more]

Vaccine Shows Therapeutic Promise Against Advanced Melanoma 
 A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, ... [more]

Melanoma Research News: Drug resistance mechanisms uncovered in most common form of melanoma 
  Researchers with UCLA’s Jonsson Comprehensive Cancer Center have found that melanoma patients whose cancers are caused by mutation of the BRAF gene become resistant to a promising targeted treatment ... [more]

Mohs Surgery for Skin Cancer 
 Mohs micrographic surgery is a specialized surgical technique that is used to remove cancers that originate in the skin. Using this technique, tissue is serially removed and processed in a manner tha... [more]

Melanoma Drug Trial News: FDA approves new drug for advanced melanoma 
 BOSTON— March 25, 2011: Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or ... [more]


These review articles are the opinions of the authors. Some of the views may be controversial. CancerNews.com™ does not directly endorse the work. We merely present it as part of our service. Please read the disclaimer.

This site is property of Net Ventures, Inc.